nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—Abnormal faeces—Hydrochlorothiazide—nephrolithiasis	0.0231	0.0362	CcSEcCtD
Pantoprazole—Blood potassium increased—Hydrochlorothiazide—nephrolithiasis	0.0219	0.0343	CcSEcCtD
Pantoprazole—ATP4B—Ion channel transport—CLCN5—nephrolithiasis	0.0211	0.0782	CbGpPWpGaD
Pantoprazole—ATP4B—Ion channel transport—CLCN4—nephrolithiasis	0.0211	0.0782	CbGpPWpGaD
Pantoprazole—ATP4A—Ion channel transport—CLCN5—nephrolithiasis	0.0188	0.0697	CbGpPWpGaD
Pantoprazole—ATP4A—Ion channel transport—CLCN4—nephrolithiasis	0.0188	0.0697	CbGpPWpGaD
Pantoprazole—CYP2C19—urine—nephrolithiasis	0.0143	0.156	CbGeAlD
Pantoprazole—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0197	CcSEcCtD
Pantoprazole—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0197	CcSEcCtD
Pantoprazole—CYP1A2—urine—nephrolithiasis	0.0116	0.127	CbGeAlD
Pantoprazole—CYP2C9—urine—nephrolithiasis	0.0111	0.121	CbGeAlD
Pantoprazole—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0109	0.017	CcSEcCtD
Pantoprazole—ATP4A—renal system—nephrolithiasis	0.00999	0.109	CbGeAlD
Pantoprazole—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.00979	0.0153	CcSEcCtD
Pantoprazole—ATP4A—kidney—nephrolithiasis	0.00966	0.105	CbGeAlD
Pantoprazole—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.00961	0.015	CcSEcCtD
Pantoprazole—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00917	0.0144	CcSEcCtD
Pantoprazole—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.00863	0.0135	CcSEcCtD
Pantoprazole—CYP3A4—urine—nephrolithiasis	0.00843	0.0921	CbGeAlD
Pantoprazole—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00816	0.0128	CcSEcCtD
Pantoprazole—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00804	0.0126	CcSEcCtD
Pantoprazole—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00752	0.0118	CcSEcCtD
Pantoprazole—Rhabdomyolysis—Hydrochlorothiazide—nephrolithiasis	0.00747	0.0117	CcSEcCtD
Pantoprazole—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00737	0.0115	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00734	0.0272	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00734	0.0272	CbGpPWpGaD
Pantoprazole—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00732	0.0115	CcSEcCtD
Pantoprazole—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00713	0.0112	CcSEcCtD
Pantoprazole—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00713	0.0112	CcSEcCtD
Pantoprazole—Gout—Hydrochlorothiazide—nephrolithiasis	0.00708	0.0111	CcSEcCtD
Pantoprazole—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.00699	0.0109	CcSEcCtD
Pantoprazole—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0069	0.0108	CcSEcCtD
Pantoprazole—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00673	0.0105	CcSEcCtD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00655	0.0242	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00655	0.0242	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00655	0.0242	CbGpPWpGaD
Pantoprazole—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.00649	0.0241	CbGpPWpGaD
Pantoprazole—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00604	0.00946	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00599	0.0222	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00599	0.0222	CbGpPWpGaD
Pantoprazole—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00598	0.00936	CcSEcCtD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00583	0.0216	CbGpPWpGaD
Pantoprazole—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00868	CcSEcCtD
Pantoprazole—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00552	0.00864	CcSEcCtD
Pantoprazole—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00547	0.00856	CcSEcCtD
Pantoprazole—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00848	CcSEcCtD
Pantoprazole—SLCO1B1—renal system—nephrolithiasis	0.00536	0.0585	CbGeAlD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00534	0.0198	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00534	0.0198	CbGpPWpGaD
Pantoprazole—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00527	0.00825	CcSEcCtD
Pantoprazole—Injury—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00818	CcSEcCtD
Pantoprazole—SLCO1B1—kidney—nephrolithiasis	0.00518	0.0565	CbGeAlD
Pantoprazole—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00518	0.00811	CcSEcCtD
Pantoprazole—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00804	CcSEcCtD
Pantoprazole—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00511	0.008	CcSEcCtD
Pantoprazole—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00509	0.00797	CcSEcCtD
Pantoprazole—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00509	0.00797	CcSEcCtD
Pantoprazole—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00506	0.00793	CcSEcCtD
Pantoprazole—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00506	0.00793	CcSEcCtD
Pantoprazole—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00504	0.0079	CcSEcCtD
Pantoprazole—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00773	CcSEcCtD
Pantoprazole—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00482	0.00755	CcSEcCtD
Pantoprazole—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00752	CcSEcCtD
Pantoprazole—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00752	CcSEcCtD
Pantoprazole—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00476	0.00746	CcSEcCtD
Pantoprazole—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00472	0.0074	CcSEcCtD
Pantoprazole—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00472	0.0074	CcSEcCtD
Pantoprazole—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00726	CcSEcCtD
Pantoprazole—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00455	0.00712	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00454	0.0168	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00454	0.0168	CbGpPWpGaD
Pantoprazole—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0045	0.00704	CcSEcCtD
Pantoprazole—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00694	CcSEcCtD
Pantoprazole—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0044	0.00689	CcSEcCtD
Pantoprazole—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00438	0.00687	CcSEcCtD
Pantoprazole—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00434	0.00679	CcSEcCtD
Pantoprazole—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00677	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00677	CcSEcCtD
Pantoprazole—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00677	CcSEcCtD
Pantoprazole—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00425	0.00665	CcSEcCtD
Pantoprazole—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00663	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00422	0.0156	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00422	0.0156	CbGpPWpGaD
Pantoprazole—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00654	CcSEcCtD
Pantoprazole—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00415	0.0065	CcSEcCtD
Pantoprazole—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00415	0.0065	CcSEcCtD
Pantoprazole—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00407	0.00637	CcSEcCtD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00404	0.015	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00404	0.015	CbGpPWpGaD
Pantoprazole—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00633	CcSEcCtD
Pantoprazole—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00388	0.00607	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00604	CcSEcCtD
Pantoprazole—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00383	0.006	CcSEcCtD
Pantoprazole—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00382	0.00598	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00593	CcSEcCtD
Pantoprazole—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00377	0.00591	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00376	0.0139	CbGpPWpGaD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00376	0.0139	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00376	0.0139	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00376	0.0139	CbGpPWpGaD
Pantoprazole—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00586	CcSEcCtD
Pantoprazole—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00372	0.00583	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00367	0.00574	CcSEcCtD
Pantoprazole—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00365	0.00571	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00363	0.00568	CcSEcCtD
Pantoprazole—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00363	0.00568	CcSEcCtD
Pantoprazole—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0036	0.00565	CcSEcCtD
Pantoprazole—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00563	CcSEcCtD
Pantoprazole—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00359	0.00563	CcSEcCtD
Pantoprazole—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00555	CcSEcCtD
Pantoprazole—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00552	CcSEcCtD
Pantoprazole—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00349	0.00546	CcSEcCtD
Pantoprazole—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00347	0.00543	CcSEcCtD
Pantoprazole—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00345	0.00541	CcSEcCtD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00335	0.0124	CbGpPWpGaD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00335	0.0124	CbGpPWpGaD
Pantoprazole—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00521	CcSEcCtD
Pantoprazole—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00332	0.0052	CcSEcCtD
Pantoprazole—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00517	CcSEcCtD
Pantoprazole—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00516	CcSEcCtD
Pantoprazole—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00512	CcSEcCtD
Pantoprazole—ABCG2—nephron tubule—nephrolithiasis	0.00326	0.0356	CbGeAlD
Pantoprazole—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0032	0.00501	CcSEcCtD
Pantoprazole—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00492	CcSEcCtD
Pantoprazole—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00485	CcSEcCtD
Pantoprazole—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00483	CcSEcCtD
Pantoprazole—ATP4B—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00301	0.0111	CbGpPWpGaD
Pantoprazole—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00297	0.00465	CcSEcCtD
Pantoprazole—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00293	0.0046	CcSEcCtD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00289	0.0107	CbGpPWpGaD
Pantoprazole—CYP1A2—renal system—nephrolithiasis	0.00285	0.0311	CbGeAlD
Pantoprazole—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00446	CcSEcCtD
Pantoprazole—Tension—Hydrochlorothiazide—nephrolithiasis	0.00284	0.00444	CcSEcCtD
Pantoprazole—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00443	CcSEcCtD
Pantoprazole—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00281	0.0044	CcSEcCtD
Pantoprazole—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0028	0.00438	CcSEcCtD
Pantoprazole—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00278	0.00435	CcSEcCtD
Pantoprazole—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00272	0.00427	CcSEcCtD
Pantoprazole—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00271	0.00424	CcSEcCtD
Pantoprazole—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00268	0.0042	CcSEcCtD
Pantoprazole—ATP4A—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00268	0.00992	CbGpPWpGaD
Pantoprazole—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00418	CcSEcCtD
Pantoprazole—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00266	0.00416	CcSEcCtD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00265	0.00981	CbGpPWpGaD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00265	0.00981	CbGpPWpGaD
Pantoprazole—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00414	CcSEcCtD
Pantoprazole—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00261	0.00408	CcSEcCtD
Pantoprazole—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00407	CcSEcCtD
Pantoprazole—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00406	CcSEcCtD
Pantoprazole—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00405	CcSEcCtD
Pantoprazole—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00255	0.004	CcSEcCtD
Pantoprazole—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00398	CcSEcCtD
Pantoprazole—Cough—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00395	CcSEcCtD
Pantoprazole—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00385	CcSEcCtD
Pantoprazole—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00385	CcSEcCtD
Pantoprazole—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00246	0.00385	CcSEcCtD
Pantoprazole—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00384	CcSEcCtD
Pantoprazole—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00243	0.00381	CcSEcCtD
Pantoprazole—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00241	0.00377	CcSEcCtD
Pantoprazole—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00238	0.00373	CcSEcCtD
Pantoprazole—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00236	0.00369	CcSEcCtD
Pantoprazole—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00236	0.00369	CcSEcCtD
Pantoprazole—Shock—Hydrochlorothiazide—nephrolithiasis	0.00232	0.00363	CcSEcCtD
Pantoprazole—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00231	0.00362	CcSEcCtD
Pantoprazole—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0023	0.00361	CcSEcCtD
Pantoprazole—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00228	0.00357	CcSEcCtD
Pantoprazole—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00352	CcSEcCtD
Pantoprazole—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00345	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00215	0.00337	CcSEcCtD
Pantoprazole—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00213	0.00334	CcSEcCtD
Pantoprazole—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00212	0.00332	CcSEcCtD
Pantoprazole—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0021	0.00329	CcSEcCtD
Pantoprazole—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0021	0.00328	CcSEcCtD
Pantoprazole—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00208	0.00325	CcSEcCtD
Pantoprazole—CYP3A4—renal system—nephrolithiasis	0.00206	0.0225	CbGeAlD
Pantoprazole—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00321	CcSEcCtD
Pantoprazole—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00319	CcSEcCtD
Pantoprazole—Pain—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00316	CcSEcCtD
Pantoprazole—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00202	0.00316	CcSEcCtD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00201	0.00743	CbGpPWpGaD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00201	0.00743	CbGpPWpGaD
Pantoprazole—CYP3A4—kidney—nephrolithiasis	0.00199	0.0218	CbGeAlD
Pantoprazole—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00194	0.00304	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00193	0.00302	CcSEcCtD
Pantoprazole—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00187	0.00293	CcSEcCtD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00186	0.00691	CbGpPWpGaD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00186	0.00691	CbGpPWpGaD
Pantoprazole—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00186	0.00292	CcSEcCtD
Pantoprazole—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00186	0.00292	CcSEcCtD
Pantoprazole—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00177	0.00657	CbGpPWpGaD
Pantoprazole—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00174	0.00272	CcSEcCtD
Pantoprazole—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00169	0.00265	CcSEcCtD
Pantoprazole—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00167	0.00261	CcSEcCtD
Pantoprazole—SLCO1B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00166	0.00616	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00165	0.00611	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00165	0.00611	CbGpPWpGaD
Pantoprazole—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00253	CcSEcCtD
Pantoprazole—ABCB1—nephron tubule—nephrolithiasis	0.00161	0.0175	CbGeAlD
Pantoprazole—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00156	0.00244	CcSEcCtD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00153	0.00566	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00153	0.00566	CbGpPWpGaD
Pantoprazole—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0015	0.00235	CcSEcCtD
Pantoprazole—Rash—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00233	CcSEcCtD
Pantoprazole—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00149	0.00233	CcSEcCtD
Pantoprazole—Headache—Hydrochlorothiazide—nephrolithiasis	0.00148	0.00231	CcSEcCtD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00147	0.00545	CbGpPWpGaD
Pantoprazole—ABCB1—renal system—nephrolithiasis	0.00146	0.0159	CbGeAlD
Pantoprazole—ABCB1—kidney—nephrolithiasis	0.00141	0.0154	CbGeAlD
Pantoprazole—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0014	0.00219	CcSEcCtD
Pantoprazole—ABCB1—cortex of kidney—nephrolithiasis	0.00137	0.015	CbGeAlD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00136	0.00504	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00135	0.00498	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00135	0.00498	CbGpPWpGaD
Pantoprazole—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.00133	0.00493	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00125	0.00461	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00125	0.00461	CbGpPWpGaD
Pantoprazole—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00121	0.0045	CbGpPWpGaD
Pantoprazole—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.00104	0.00384	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00102	0.00378	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00102	0.00378	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000948	0.00351	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000948	0.00351	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000944	0.0035	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000944	0.0035	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000877	0.00325	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000877	0.00325	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000845	0.00313	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000845	0.00313	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000826	0.00306	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000826	0.00306	CbGpPWpGaD
Pantoprazole—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000801	0.00297	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000782	0.0029	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000782	0.0029	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000736	0.00273	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000675	0.0025	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000673	0.00249	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000673	0.00249	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000625	0.00232	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GRHPR—nephrolithiasis	0.000586	0.00217	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000542	0.00201	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AGXT—nephrolithiasis	0.000522	0.00193	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00051	0.00189	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00051	0.00189	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000483	0.00179	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000474	0.00176	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000474	0.00176	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—SLC26A1—nephrolithiasis	0.000444	0.00164	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—APRT—nephrolithiasis	0.000444	0.00164	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000423	0.00157	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000423	0.00157	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—APRT—nephrolithiasis	0.000411	0.00152	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000411	0.00152	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000338	0.00125	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AQP1—nephrolithiasis	0.000316	0.00117	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.0003	0.00111	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000293	0.00109	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000293	0.00108	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CHRM3—nephrolithiasis	0.000286	0.00106	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000274	0.00101	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000268	0.000992	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000265	0.000981	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000261	0.000968	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000244	0.000904	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000234	0.000867	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000228	0.000843	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000228	0.000843	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—APRT—nephrolithiasis	0.000222	0.000823	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000222	0.000823	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000209	0.000773	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000208	0.000769	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000208	0.000769	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000181	0.000669	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000177	0.000657	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000177	0.000657	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.000162	0.000601	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000161	0.000596	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000158	0.000587	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000148	0.000548	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.000147	0.000543	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000143	0.00053	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000137	0.000507	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000137	0.000507	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000134	0.000496	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AQP1—nephrolithiasis	0.000126	0.000468	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CHRM3—nephrolithiasis	0.000114	0.000423	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AQP1—nephrolithiasis	9.75e-05	0.000361	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CHRM3—nephrolithiasis	8.82e-05	0.000327	CbGpPWpGaD
